TAHER M KHALIL
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology RIVERSIDE, CA NPI 1962458752
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology CA Amgen Inc. All categories
General Payments — all program years on this page
$5,006.99
- Category: General Payments
- Program years: PY2018–2024
- Record count: 218
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,007.44 across 43 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,007.44 | 43 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $159.71 | 6 |
| NXSTAGE MEDICAL, INC. | $100.32 | 1 |
| Ardelyx, Inc. | $98.16 | 5 |
| CALLIDITAS THERAPEUTICS US INC. | $86.08 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $75.10 | 4 |
| AKEBIA THERAPEUTICS INC | $74.69 | 3 |
| Acerta Pharma LLC | $73.65 | 5 |
| Retrophin, Inc. | $48.91 | 2 |
| Otsuka America Pharmaceutical, Inc. | $48.34 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $46.50 | 2 |
| Aurinia Pharma U.S., Inc. | $45.33 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $44.45 | 2 |
| ANI Pharmaceuticals, Inc. | $28.54 | 1 |
| Alexion Pharmaceuticals, Inc. | $23.52 | 1 |
| Relypsa, Inc. | $20.89 | 1 |
| Fresenius USA Marketing, Inc. | $17.63 | 1 |
| Medtronic, Inc. | $15.62 | 1 |
By program year
Records — PY2024 (43)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.